Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial: Empagliflozin after Myocardial Infarction
- on behalf of the EMMY study group
Research output: Contribution to journal › Article › peer-review
60
Link opens in a new tab
Citations
(Scopus)